Abstract
Objective. Inflammatory bowel disease (IBD) is generally reported to be associated with spondylarthropathies (SpA) in 5%–15% of cases. Systematic colonoscopic assessment by protocol demonstrated mucosal inflammation characteristic of Crohn disease (CD) in up to one-third of patients with SpA. Video capsule endoscopy (CE) is a superior diagnostic tool to detect small bowel mucosal disease. Our study compared the accuracy of CE to standard colonoscopy for detection of inflammatory bowel lesions in patients with SpA, and to describe predictors of small bowel inflammation (SBI) in this cohort.
Methods. Prospective cross-sectional study of adult patients followed for SpA. Patients were evaluated by CE and standard colonoscopy with biopsies. SBI was quantified using the Lewis Score. Additional screening tests included fecal calprotectin (FCP), C-reactive protein (CRP), and a diagnostic panel of serologic, inflammatory and genetic tests (SGI).
Results. There were 64 patients recruited (53% female, mean age 42 ± 13 yrs). Chronic gastrointestinal (GI) symptoms were present in 57%. CE revealed significant SBI in 27/64 (42.2%), compared to 7/64 (10.9%) by standard colonoscopy (p = 0.035). Elevated FCP was associated with small bowel CD (OR 4.5, 95% CI 1.01–19.9; p = 0.042). No correlation was observed with presence of GI symptoms, CRP, or SGI results. Finding CD led to a change in management in 65.2% of cases.
Conclusion. CE uncovered SBI consistent with CD in 42.2% of patients with SpA, with a significant incremental yield over colonoscopy of 31%. FCP levels were significantly correlated with CE results, while GI symptoms and SGI results were poor predictors of SBI.
Footnotes
Full Release Article. For details see Reprints and Permissions at jrheum.org
Financial support for our research study was provided by Abbvie Canada as an unrestricted grant. In-kind research support (EGS) was provided by Given Imaging/Medtronic Inc., and Prometheus Laboratories. Salary support (EGS) funded by the Canada Research Chair in Immune-mediated Gastrointestinal Disorders and the Bruce Kaufman Endowed Chair in Inflammatory Bowel Diseases (IBD) at McGill University. Fellowship awards funded by the McGill IBD Research Group (Dr. Kopylov) and the Fondation Litta of Geneva, Switzerland (MG).
- Accepted for publication October 11, 2017.
Free online via JRheum Full Release option